Minimal Residual Disease in Mantle Cell Lymphoma: Methods and Clinical Significance
Hematology/Oncology Clinics of North America(2020)
摘要
Several biological and clinical features have been recognized in mantle cell lymphoma (MCL). In recent years, the minimal residual disease (MRD) has been extensively investigated and is now considered as one of the strongest clinical predictors in this lymphoma. This article reviews methods used for the assessment of MRD in MCL and discusses their strengths and weaknesses. In addition, it examines the MRD contribution to the biology knowledge of MCL and the development of effective strategies for its management, including the possibility of personalized treatment based on MRD response.
更多查看译文
关键词
Polymerase chain,Reaction,Next-generation sequencing,Molecular response,Molecular relapse
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要